Moderna, Inc. (MRNA) financial statements (2022 and earlier)

Company profile

Business Address 200 TECHNOLOGY SQUARE
CAMBRIDGE, MA 02139
State of Incorp. DE
Fiscal Year End December 31
SIC 2836 - Biological Products, Except Diagnostic Substances (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments10,7274,6081,1031,521
Cash and cash equivalents6,8482,624236658
Short-term investments3,8791,984867863
Restricted cash and investments 111
Receivables3,2451,4001220
Inventory, net of allowances, customer advances and progress billings1,44147  
Inventory1,44147  
Prepaid expense12616810
Derivative instruments and hedges, assets21   
Other current assets55   
Other undisclosed current assets456227410
Total current assets:16,0716,2981,1291,563
Noncurrent Assets
Finance lease, right-of-use asset6655510
Operating lease, right-of-use asset1429086
Property, plant and equipment   212
Long-term investments and receivables6,843639160173
Long-term investments6,843639160173
Restricted cash and investments12111112
Deferred income tax assets326  
Other noncurrent assets34223
Other undisclosed noncurrent assets576242192 
Total noncurrent assets:8,5981,039461399
TOTAL ASSETS:24,6697,3371,5891,962
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities2,65048875110
Accounts payable30218731
Accrued liabilities1,4724706879
Taxes payable876   
Deferred revenue6,2533,86763
Other liabilities2253453
Other undisclosed current liabilities   109
Total current liabilities:9,1284,389143223
Noncurrent Liabilities
Long-term debt and lease obligation705207132 
Finance lease, liability59911039
Operating lease, liability1069794
Liabilities, other than long-term debt69117913910
Deferred revenue615177139
Deferred rent credit   10
Other liabilities76200
Other undisclosed noncurrent liabilities   199
Total noncurrent liabilities:1,396387271209
Total liabilities:10,5244,775415432
Stockholders' equity
Stockholders' equity attributable to parent14,1452,5611,1751,530
Common stock 000
Additional paid in capital4,2114,8022,6692,538
Accumulated other comprehensive income (loss)(24)32(1)
Retained earnings (accumulated deficit)9,958(2,244)(1,496)(1,007)
Total stockholders' equity:14,1452,5611,1751,530
TOTAL LIABILITIES AND EQUITY:24,6697,3371,5891,962

Income statement (P&L) ($ in millions)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
Revenues18,47180360135
Cost of revenue
(Cost of Goods and Services Sold)
(2,617)(8)  
Gross profit:15,85479560135
Operating expenses(2,558)(1,559)(606)(548)
Operating income (loss):13,296(763)(546)(413)
Nonoperating income (expense)(11)193129
Investment income, nonoperating18253927
Other nonoperating income (expense)(29)(6)(8)2
Interest and debt expense(17)(10)(7) 
Other undisclosed income from continuing operations before equity method investments, income taxes 107 
Income (loss) from continuing operations before equity method investments, income taxes:13,268(745)(515)(384)
Other undisclosed income from continuing operations before income taxes17   
Income (loss) from continuing operations before income taxes:13,285(745)(515)(384)
Income tax expense (benefit)(1,083)(3)1(0)
Net income (loss) attributable to parent:12,202(747)(514)(385)
Preferred stock dividends and other adjustments   (17)
Net income (loss) available to common stockholders, diluted:12,202(747)(514)(402)

Comprehensive Income ($ in millions)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
Net income (loss):12,202(747)(514)(385)
Comprehensive income (loss):12,202(747)(514)(385)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(27)13(0)
Comprehensive income (loss), net of tax, attributable to parent:12,175(746)(511)(385)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: